Navigation Links
Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment
Date:7/1/2009

- decreased appetite, difficulty falling asleep, and dry mouth.

Aggression, new abnormal thoughts/behaviors, mania, growth suppression, worsening of motion or verbal tics, and Tourette's syndrome have been associated with use of drugs of this type. Tell the doctor if you or your child has blurred vision while taking Vyvanse.

About ADHD

ADHD is one of the most common psychiatric disorders in children and adolescents. Worldwide prevalence of ADHD is estimated at 5.3 percent (with large variability), according to a comprehensive systematic review of this topic published in 2007 in the American Journal of Psychiatry. In the United States, approximately 7.8 percent of all school-aged children, or about 4.4 million children aged 4 to 17 years, have been diagnosed with ADHD at some point in their lives, according to the Centers for Disease Control and Prevention (CDC). The disorder is also estimated to affect 4.4 percent of US adults aged 18 to 44 based on results from the National Comorbidity Survey Replication. When this percentage is extrapolated to the full US population aged 18 and over, approximately 9.8 million adults are believed to have ADHD.

ADHD is a psychiatric behavioral disorder that manifests as a persistent pattern of inattention and/or hyperactivity-impulsivity that is more frequent and severe than is typically observed in individuals at a comparable level of development. The specific etiology of ADHD is unknown and there is no single diagnostic test for this syndrome. Adequate diagnosis requires the use of medical and special psychological, educational and social resources, utilizing diagnostic criteria such as Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) or International Classification of Diseases 10 (ICD-10).

Although there is no "cure" for ADHD, there are accepted treatments that specifically target its symptoms. St
'/>"/>

SOURCE Shire plc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine
2. Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cutaneous T-cell Lymphoma
3. SRNL to study applicability of solar cell coatings
4. Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide
5. Independent U.S. Study Confirms Veritides Ceeker(TM) Handheld Device Detects Anthrax With Outstanding Accuracy and Reliability
6. New England Journal of Medicine Study Highlights Need for Rapid, PCR-based Group B Streptococcus (GBS) Testing at Time of Admission for Labor and Delivery
7. Advanced Life Sciences Restanza(TM) Shows 100% Survival In Confirmatory Anthrax Study
8. Springborn Deploys eStudy(TM) Hosted Solution for Management of Global Environmental Testing
9. AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule
10. AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia
11. Clinical Pharmacology Study With AZILECT(R) (Rasagiline Tablets) Demonstrated It Does Not Increase Tyramine Sensitivity

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,Ontario,Nov.24/PRNewswire-FirstCall/--DowAgroScie...landSeeds,adivisionofThompsonsLimitedofBlenheim,On...AgroSciences,currentseedsbusinessasthecompanyantic...dDowAgroSciencesHerbicideTolerantTraitTechnologyin...rfuture. ,, "Thisacquisitionbringstogethertwost...
(Date:11/24/2009)... Health care employment grew by 29,000 jobs in Oc...consistent growth during the U.S. recession. Howev...ble, and health systems are coming closer to havin...st administrators. , (Voc...ntinued growing in October despite the shedding of...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq:...ngandcommercializingnovelpainmanagementtherapies,a...xecutiveOfficer,isscheduledtopresentatthe21stAnnua...1-2,2009atTheNewYorkPalaceHotelinNewYork,NewYork. ...Officer,willbeavailabletorespondtoquestionsduringt...
(Date:11/24/2009)...The FBI recently approved the Promega PowerPlex 16...n or generating DNA records for the National DNA I...I USA (PRWEB) -- The FBI recently approved the Pro...ratories participating in, or generating DNA recor... currently contains more than seven million profil...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...edical Systems, Growing Network of Medical Technol...Year of Profitability in 2007., PLEASANTON, Calif...an office in Russia to open a distribution network...lted in the registration of DMS,s,InNovaSound USB ... medical,providers in Russia., (Logo: http://www...
..., Calif., May 16 Immunosyn,Corporation (OTC Bulle...tained exclusive worldwide marketing, sales and di... from its affiliate Argyll Biotechnologies,LLC, ha...ch 31, 2008., For the quarter ended March 31, 200... administrative expenses and $13,393.00 in interes...
..., Calif., May 16 InterMune, Inc.,(Nasdaq: ITMN )...esident and,Chief Financial Officer of InterMune, ...re Conference in New York on May 22, 2008 at 1:30 ...presentation, investors and other,interested parti...terMune,s,corporate website at http://www.intermu...
Other Biology Technology:Direct Medical Systems Reaches Profitability in 2-1/2 Years, as a Result of Sales of the World's Smallest and Lightest Ultrasound System, the InNovaSound USB Ultrasound. 2Immunosyn Corporation Files 10-Q 2Immunosyn Corporation Files 10-Q 3
(Date:11/24/2009)...held secrets of the earth,s history locked in its ...y little information on the environments that have...years. Now, a team of researchers from nine instit...e of $10 million dollars by the National Science F... literally. These scientists will drill through th...
(Date:11/23/2009)...ociated strain of the deadly superbug MRSAan infec...ibioticsposes a far greater health threat than pre..., according to a study in the December issue of E...is easily picked up in fitness centers, schools, a...ll burden of MRSA within hospitals, the report fou...
(Date:11/23/2009)...ggests that a common oral bacterium may exacerbate...s et al, "Unique Lipids from a Common Human Bacter...of Enhancing Autoimmunity," appears in the Decembe... . , Multiple sclerosis (MS), a disease where th... affects nearly 1 in 700 people in the United Stat...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 1Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 2Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 3Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 4Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday October 6 2009 to Announce Top Line Phase 3 Study Results for Lead Topical P 14353 1Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday October 6 2009 to Announce Top Line Phase 3 Study Results for Lead Topical P 14353 2Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday October 6 2009 to Announce Top Line Phase 3 Study Results for Lead Topical P 14353 3Regado Biosciences To Present at the 2009 Japan Biopharma Partnering Conference on October 6 2009 14348 1Regado Biosciences To Present at the 2009 Japan Biopharma Partnering Conference on October 6 2009 14348 2
...more than half of children with sore throat, excee...used nonrecommended antibiotics for 27 percent of ...according to a study in the November 9 issue of JA...ounts for 6 percent of visits by children to famil... to background information in the article. The mos...
...e have demonstrated that Langerhans cells in the s...stem to pathogens, instead dampen the skin,s react...potential to significantly alter understanding of ... as psoriasis, lupus and skin cancer. , Dendriti...emely efficient at alerting the immune system to t...
...iated with an increased risk of hypertension in wo...nsumption of sugared or diet colas, according to a...ately 50 million people in the United States have ...cording to background information in the article. ...eart disease, stroke, and congestive heart failure...
Other Biology News:Children overprescribed antibiotics for sore throat 2Langerhans cells regulate immune reactions in the skin 2No link found between caffeine intake and development of hypertension in women 2
Distillation Hood from Terra Universal, Inc.
Endotoxin Gel formation Assay Kit, E-TOXATE from Sigma-Aldrich
...l safety labs (BSL) and pharmaceutical application... easy sterilization. Panels are precision-joined t...pe down and disinfect. One-inch radius corners sim...eates strong, rigid surface without external braci...
Stainless Steel Glove Boxes from Terra Universal, Inc.
Biology Products: